Literature DB >> 6607975

Chronic lymphocytic leukemia and other chronic lymphoid proliferations: surface marker phenotypes and clinical correlations.

R O Dillman, J C Beauregard, J W Lea, M R Green, R E Sobol, I Royston.   

Abstract

A diagnosis of chronic lymphocytic leukemia (CLL) was made in 81 patients referred for peripheral blood lymphocyte typing (PBL). A retrospective review was undertaken to see if correlations existed between surface marker phenotype-determined subclasses and clinical features. Surface markers utilized were surface immunoglobulin (sIg), sheep erythrocyte receptor (E), 65,000-dalton human T lymphocyte antigen (T65), Ia antigen, and for sIg+ cells, heavy and light chains. All patients were Ia+. Cells of 70% of patients were sIg+ E- T65+ Ia+, and the clinical heterogeneity was that of classical CLL. Eight of the nine patients with sIg+ E- T65- Ia+ cells had a paraprotein. The sIg- E+ T65+ Ia+ phenotype represented classical T cell CLL. Three of the five patients in the sEg- E- T65+ Ia+ group had significant albuminuria, and two had nephrotic-range proteinuria. Use of additional monoclonal antibodies to B cell surface antigens should further subclassify CLL and other lymphoproliferative disorders. Interesting clinical correlations with certain phenotypic subclasses do exist, and further subclassification and long-term follow-up may yield correlations between phenotypes and prognosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6607975     DOI: 10.1200/JCO.1983.1.3.190

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  4 in total

1.  Repeated pentostatin (2'deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia.

Authors:  R O Dillman; A L Yu; C N Qiao
Journal:  West J Med       Date:  1988-03

2.  "Well-differentiated" lymphocytic neoplasms. Immunologic findings correlated with clinical presentation and morphologic features.

Authors:  L J Medeiros; J G Strickler; L J Picker; A B Gelb; L M Weiss; R A Warnke
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

3.  Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience.

Authors:  M J Borowitz; A Bousvaros; R K Brynes; J B Cousar; J D Crissman; C C Whitcomb; B J Kerns; G E Byrne
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

4.  Characterization of chronic lymphocytic leukemia (CLL) cells with low density of surface membrane bound immunoglobulins (smIg).

Authors:  E Kimby; B Axelsson; M Björkholm; J Gordon; G Holm; H Mellstedt
Journal:  Med Oncol Tumor Pharmacother       Date:  1985
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.